CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue:
Total revenue	$ 3,367,324	$ 3,215,360	$ 2,706,655
Cost of Revenue:
Total cost of revenue	1,362,986	1,325,928	1,135,615
Gross profit	2,004,338	1,889,432	1,571,040
Expenses:
Sales and marketing	524,505	486,735	434,435
General and administrative	326,248	309,660	300,832
Research and development	254,820	161,009	141,249
Income from operations	898,765	932,028	694,524
Interest expense	(39,858)	(29,808)	(33,125)
Interest income	1,065	434	586
Income before provision for income taxes	859,972	902,654	661,985
Provision for income taxes	180,883	157,810	79,854
Net income	679,089	744,844	582,131
Less: Net (loss) income attributable to noncontrolling interest	0	(1)	355
Net income attributable to IDEXX Laboratories, Inc. stockholders	$ 679,089	$ 744,845	$ 581,776
Earnings per Share:
Basic (in USD per share)	$ 8.12	$ 8.74	$ 6.82
Diluted (in USD per share)	$ 8.03	$ 8.60	$ 6.71
Weighted Average Shares Outstanding:
Basic (in shares)	83,623	85,200	85,342
Diluted (in shares)	84,600	86,572	86,722
Product revenue
Revenue:
Total revenue	$ 1,928,773	$ 1,875,308	$ 1,586,809
Cost of Revenue:
Total cost of revenue	656,511	656,823	557,795
Service revenue
Revenue:
Total revenue	1,438,551	1,340,052	1,119,846
Cost of Revenue:
Total cost of revenue	$ 706,475	$ 669,105	$ 577,820